Patents by Inventor Andreas Nils Walter HERBST

Andreas Nils Walter HERBST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10731132
    Abstract: The invention relates to method for the separation of cord blood endothelial cells from hematopoietic cells in a manner that preserves the hematopoietic cells' repopulating ability and primitivity, without significantly reducing the yield of hematopoietic cells. The said endothelial cells from cord blood have a utility in cell based therapeutics. The system described takes advantage of the endogenous adherence properties of the cells to facilitate the separation and separate storage of the cell types.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: August 4, 2020
    Assignee: Amniotics AB
    Inventors: Marcus Kare Torleif Larsson, Andreas Nils Walter Herbst, Niels-bjarne Roland Woods
  • Publication number: 20200171097
    Abstract: Disclosed herein are methods and apparatuses for the safe, high-yield collection of sterile amniotic fluid. The apparatus are configured to allow sufficient flexibility for the device to gain access to all areas of the amniotic cavity, to allow sufficient stiffness for the amniotic fluid collection device to puncture the amniotic and chorionic membranes, yet allow sufficient suppleness to pose no significant risk of maternal or fetal harm. Further disclosed are cells isolated from the full-term amniotic fluid, and methods for using, reprogramming, and differentiating these cells.
    Type: Application
    Filed: January 3, 2020
    Publication date: June 4, 2020
    Inventors: Marcus Kare Torleif Larsson, Andreas Nils Walter Herbst, Niels-bjarne Roland Woods
  • Publication number: 20160068815
    Abstract: The invention relates to method for the separation of cord blood endothelial cells from hematopoietic cells in a manner that preserves the hematopoietic cells' repopulating ability and primitivity, without significantly reducing the yield of hematopoietic cells. The said endothelial cells from cord blood have a utility in cell based therapeutics. The system described takes advantage of the endogenous adherence properties of the cells to facilitate the separation and separate storage of the cell types.
    Type: Application
    Filed: March 14, 2014
    Publication date: March 10, 2016
    Inventors: Marcus Kare Torleif LARSSON, Andreas Nils Walter HERBST, Niels-bjarne Roland WOODS
  • Publication number: 20160030489
    Abstract: Disclosed herein are methods and apparatuses for the safe, high-yield collection of sterile amniotic fluid. The apparatus are configured to allow sufficient flexibility for the device to gain access to all areas of the amniotic cavity, to allow sufficient stiffness for the amniotic fluid collection device to puncture the amniotic and chorionic membranes, yet allow sufficient suppleness to pose no significant risk of maternal or fetal harm. Further disclosed are cells isolated from the full-term amniotic fluid, and methods for using, reprogramming, and differentiating these cells.
    Type: Application
    Filed: March 14, 2014
    Publication date: February 4, 2016
    Inventors: Marcus Kare Torleif LARSSON, Andreas Nils Walter HERBST, Niels-bjarne Roland WOODS